563 related articles for article (PubMed ID: 9301473)
1. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in the retinal pigment epithelium and interphotoreceptor matrix: vectorial secretion and regulation.
Padgett LC; Lui GM; Werb Z; LaVail MM
Exp Eye Res; 1997 Jun; 64(6):927-38. PubMed ID: 9301473
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium.
Alexander JP; Bradley JM; Gabourel JD; Acott TS
Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2520-8. PubMed ID: 2176183
[TBL] [Abstract][Full Text] [Related]
3. Modulation of matrix metalloproteinase and TIMP-1 expression by cytokines in human RPE cells.
Eichler W; Friedrichs U; Thies A; Tratz C; Wiedemann P
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2767-73. PubMed ID: 12147614
[TBL] [Abstract][Full Text] [Related]
4. Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues.
Lokeshwar BL; Selzer MG; Block NL; Gunja-Smith Z
Cancer Res; 1993 Oct; 53(19):4493-8. PubMed ID: 7691397
[TBL] [Abstract][Full Text] [Related]
5. Expression of metalloproteinases from human retinal pigment epithelial cells and their effects on the hydraulic conductivity of Bruch's membrane.
Ahir A; Guo L; Hussain AA; Marshall J
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):458-65. PubMed ID: 11818391
[TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
7. Drusen are Cold Spots for Proteolysis: Expression of Matrix Metalloproteinases and Their Tissue Inhibitor Proteins in Age-related Macular Degeneration.
Leu ST; Batni S; Radeke MJ; Johnson LV; Anderson DH; Clegg DO
Exp Eye Res; 2002 Jan; 74(1):141-54. PubMed ID: 11878827
[TBL] [Abstract][Full Text] [Related]
8. Retinal pigment epithelium produces matrix metalloproteinases after laser treatment.
Flaxel C; Bradle J; Acott T; Samples JR
Retina; 2007 Jun; 27(5):629-34. PubMed ID: 17558327
[TBL] [Abstract][Full Text] [Related]
9. Characterization and novel activation of 72-kDa metalloproteinase in retinal interphotoreceptor matrix and Y-79 cell culture medium.
Jones BE; Moshyedi P; Gallo S; Tombran-Tink J; Arand G; Reid DA; Thompson EW; Chader GJ; Waldbillig RJ
Exp Eye Res; 1994 Sep; 59(3):257-69. PubMed ID: 7821370
[TBL] [Abstract][Full Text] [Related]
10. Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and dexamethasone.
el-Shabrawi Y; Eckhardt M; Berghold A; Faulborn J; Auboeck L; Mangge H; Ardjomand N
Eye (Lond); 2000 Jun; 14 ( Pt 3A)():375-83. PubMed ID: 11027004
[TBL] [Abstract][Full Text] [Related]
11. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
Terada T; Okada Y; Nakanuma Y
Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes.
Steen B; Sejersen S; Berglin L; Seregard S; Kvanta A
Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2194-200. PubMed ID: 9761302
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and their inhibitors.
Kugler A
Anticancer Res; 1999; 19(2C):1589-92. PubMed ID: 10365151
[TBL] [Abstract][Full Text] [Related]
14. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
15. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements.
Yokohama Y; Matsumoto T; Hirakawa M; Kuroki Y; Fujimoto N; Imai K; Okada Y
Lab Invest; 1995 Dec; 73(6):899-911. PubMed ID: 8558853
[TBL] [Abstract][Full Text] [Related]
16. Dynamic expression of matrix metalloproteinases (MMP-2, -9 and -14) and the tissue inhibitors of MMPs (TIMP-1, -2 and -3) at the implantation site during tubal pregnancy.
Bai SX; Wang YL; Qin L; Xiao ZJ; Herva R; Piao YS
Reproduction; 2005 Jan; 129(1):103-13. PubMed ID: 15615902
[TBL] [Abstract][Full Text] [Related]
17. Localization of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors for MMPs (TIMPs) in uterine natural killer cells in early human pregnancy.
Naruse K; Lash GE; Innes BA; Otun HA; Searle RF; Robson SC; Bulmer JN
Hum Reprod; 2009 Mar; 24(3):553-61. PubMed ID: 19088110
[TBL] [Abstract][Full Text] [Related]
18. Extracellular matrix alterations precede vascularization of the retinal pigment epithelium in dystrophic rats.
Caldwell RB
Curr Eye Res; 1989 Sep; 8(9):907-21. PubMed ID: 2477195
[TBL] [Abstract][Full Text] [Related]
19. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
Ozen O; Krebs B; Hemmerlein B; Pekrun A; Kretzschmar H; Herms J
Clin Cancer Res; 2004 Jul; 10(14):4746-53. PubMed ID: 15269148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
